Massachusetts, who overhauled their health-care in 2006 along the same terms as Obama’s Affordable Care Act, is now showing the failures we can expect to see with the national model.
Recent calls for tighter clinical requirements for medical devices should themselves be recalled. Such requirements would not greatly increase public safety; they would hamper innovation.
Why does Health and Human Services want to exempt millions of consumers from an ObamaCare regulation it just implemented to protect consumers?
With no end to the obesity epidemic in sight, several states and cities have proposed soda taxes on sugar-sweetened soda and other beverages. At this conference, experts John E. Calfee of AEI and Jamie Chriqui of the University of Illinois at Chicago will analyze the evidence on soda taxes and other measures.
Left ventricular assist devices, or “heart pumps,” are proving to be the best available option for patients with advanced heart failure, and the technology has huge potential for improvement.
The campaign against the most valuable medical technologies ever invented is based on junk science.
Crucial improvements for women are a routine byproduct of the search for new profits by international firms.
The Avandia issue has shed light on important issues in FDA regulation, including politics and regulating the practice of medicine.
There is practically no reliable scientific support for using the soda tax to fight obesity. The tax is an impulse to generate new revenue and not a creative public health measure.